Clinically, we observed that an increased frequency of tumor-blood overlapping clones in blood CD8+ T cells before treatment was associated with a favorable clinical response to PD-1 blockade in gastrointestinal cancer (32). The gene discussed is CD8A; the disease is neoplasm.